Pfizer Inc
Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%
Pfizer Allowance against trade accounts receivable by Quarter
Allowance against trade accounts receivable — Chargebacks, discounts & returns ($M) ($M)
Pfizer Allowance against trade accounts receivable: $1,741M in Q2 2026, up 9.6% from a year earlier.
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K Note 17 — Revenue Deductions & Rebate Accruals.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Allowance against trade accounts receivable — Chargebacks, discounts & returns ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 28, 2026 | 1,741 | +9.6% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2026 | Mar 29, 2026 | 1,699 | +16.2% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2025 | Dec 31, 2025 | 1,803 | +10.8% | Form 10-Q (filed 2026-08-04) ↗ |
| Q3 2025 | Sep 28, 2025 | 2,148 | +9.9% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2025 | Jun 29, 2025 | 1,589 | +0.7% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 30, 2025 | 1,462 | -7.1% | Form 10-Q (filed 2025-05-05) ↗ |
| Q4 2024 | Dec 31, 2024 | 1,627 | -8.1% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2024 | Sep 29, 2024 | 1,955 | +22.3% | Form 10-Q (filed 2024-11-04) ↗ |
| Q2 2024 | Jun 30, 2024 | 1,578 | +27.7% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 1,573 | +47.3% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2023 | Dec 31, 2023 | 1,770 | +47.5% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2023 | Oct 1, 2023 | 1,599 | – | Form 10-Q (filed 2023-11-08) ↗ |
| Q2 2023 | Jul 2, 2023 | 1,236 | – | Form 10-Q (filed 2023-08-09) ↗ |
| Q1 2023 | Apr 2, 2023 | 1,068 | – | Form 10-Q (filed 2023-05-10) ↗ |
| Q4 2022 | Dec 31, 2022 | 1,200 | +11.4% | Form 10-K (filed 2024-02-22) ↗ |
| Q4 2021 | Dec 31, 2021 | 1,077 | +25.1% | Form 10-K (filed 2023-02-23) ↗ |
| Q4 2020 | Dec 31, 2020 | 861 | +4.6% | Form 10-K (filed 2022-02-24) ↗ |
| Q4 2019 | Dec 31, 2019 | 823 | – | Form 10-K (filed 2021-02-25) ↗ |
Cite this data
StockData. (2026). Pfizer Allowance against trade accounts receivable ($M), quarterly Q4 2019–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/gtn-ar-reserve
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.